clinical trial · NCT07083206
A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe
Ahn-Gook Pharmaceuticals Co.,Ltd·—·recruiting·n = 4,500
HypercholesterolemiaDyslipidemias
brief summary
The objective of this study is to evaluate the effectiveness and safety of Pitavastatin/Ezetimibe FDC in patients with hypercholesterolemia.
started
Jul 29, 2025
primary completion
Jul 1, 2028
completion
Jan 1, 2029
last updated
Aug 7, 2025
official title
A Multi-center, Prospective, Non-intervention, Observational Study to Evaluate the Effectiveness and Safety of Switching to Pevarozet Tablet in Patients With Hypercholesterolemia Previously Treated With Atorvastatin or Rosuvastatin Monotherapy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol